Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Volska Kristine"

From Bioblast
(Created page with "{{Person}}")
ย 
ย 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{Person}}
{{EAGLE
|COST= Member
|COST WG1=WG1
}}
{{Person
|lastname=Volska
|firstname=Kristine
|institution=[[File:Volska K.JPG|300px|right|Kristina Volska]] Laboratory of Pharmaceutical Pharmacology,
ย 
Latvian Institute of Organic Synthesis, LV
ย 
|address=Aizkraukles Street 21
|area code=LV-1006
|city=Riga
|country=Latvia
|Institution=
|Area_Code=
|City=
|State_/_Province=
|Country_name=
|Weblink=
|Field_of_research=
|Topics=
}}
{{Labelingperson
|field of research=Basic
|Institution=
|Area_Code=
|City=
|State_/_Province=
|Country_name=
|Weblink=
|Field_of_research=
|Topics=
}}
ย 
ย 
== Participated at ==
ย 
::::*[[MiP2018/MitoEAGLE Jurmala LV|MitoEAGLE 2018 Jurmala LV]]
::::* [[IOC109| IOC109 Schroecken AT]]
::::* [[IOC105| IOC105 Riga LV]]
::::* [[MiPNet18.08_MiP2013|MiP2013 Obergurgl AT]]
ย 
== Visiting scientist in the Oroboros O2k-Laboratory ==
ย 
:::: [[Image:O2k-Network.png|left|40px|link=O2k-Network|O2k-Network]]
[[ Volska Kristine|ย  Kristine Volska]]: Visiting scientist at the [[Oroboros Laboratories: visiting scientists |Oroboros O2k-Laboratory]]
::::::* March 01 to April 01 2016

Latest revision as of 13:52, 17 March 2020


MiPsociety
News and Events        
BEC 2020.1 Mitochondrial physiology
       
MitoEAGLE
        Working Groups         Short-Term Scientific Missions         Management Committee         Members        
MitoGlobal
   


EU-logo.jpg

COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


Volska Kristine


MitoPedia topics: EAGLE 

COST: Member COST WG1: WG1


Name Volska Kristine,
Institution
Kristina Volska
Laboratory of Pharmaceutical Pharmacology,

Latvian Institute of Organic Synthesis, LV

Address Aizkraukles Street 21, LV-1006
City Riga
State/Province
Country Latvia
Email [email protected]
Weblink
O2k-Network Lab LV Riga Liepins E


Labels: Field of research: Basic 



Publications

 PublishedReference
BEC 2020.1 doi10.26124bec2020-0001.v12020Gnaiger E et al โ€• MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1
Makrecka-Kuka 2017 Toxicol Lett2017Makrecka-Kuka M, Volska K, Antone U, Vilskersts R, Grinberga S, Bandere D, Liepinsh E, Dambrova M (2017) Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Toxicol Lett 267:32-8.
Makrecka-Kuka 2017 Sci Rep2017Makrecka-Kuka M, Sevostjanovs E, Vilks K, Volska K, Antone U, Kuka J, Makarova E, Pugovics O, Dambrova M, Liepinsh E (2017) Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues. Sci Rep 7:17528.
Liepinsh 2016 Biochem J2016Liepinsh E, Makrecka-Kuka M, Volska K, Kuka J, Makarova E, Antone U, Sevostjanovs E, Vilskersts R, Strods A, Tars K, Dambrova M (2016) Long-chain acylcarnitines determine ischaemia/reperfusion-induced damage in heart mitochondria. Biochem J 473:1191-202.

Abstracts

 PublishedReference
Volska 2018 MiP20182018
Kristina Volska
The mechanisms of long-chain acylcarnitine accumulation during ischemia.
Makrecka-Kuka 2016 Abstract MitoFit Science Camp 20162016Long-chain acylCoAs vs acylcarnitines in mitochondrial bioenergetics: from in vitro to in vivo.
Makrecka 2013 Abstract MiP20132013Makrecka-Kuka M, Volska K, Kuka J, Liepins E, Dambrova M (2013) The accumulation of long chain acyl-carnitines is a major cause of mitochondrial damage during ischemia. Mitochondr Physiol Network 18.08.
Volska 2013 Abstract MiP20132013Volska K, Makrecka-Kuka M, Svalbe B, Dambrova M (2013) The inhibitor of L-carnitine biosynthesis protects brain mitochondria against anoxia-reoxygenation injury. Mitochondr Physiol Network 18.08.


Participated at

Visiting scientist in the Oroboros O2k-Laboratory

O2k-Network

Kristine Volska: Visiting scientist at the Oroboros O2k-Laboratory

  • March 01 to April 01 2016